Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy

Background: The Supreme healing-targeted drug-eluting stent (DES) is designed to promote endothelial healing to reduce stent-related adverse events. This may be particularly relevant among complex lesions that have a higher rate of adverse events. We sought to compare 1-year outcomes of percutaneous...

Descripció completa

Dades bibliogràfiques

Autors principals:	Kush P. Patel, MBBS, Alexandra J. Lansky, MD, Dean J. Kereiakes, MD, Stephan Windecker, MD, Ecaterina Cristea, MD, Cody Pietras, BA, Ovidiu Dressler, MD, M. Ozgu Issever, MS, Michael Curtis, MD, Barry Bertolet, MD, James P. Zidar, MD, Pieter C. Smits, MD, Victor Alfonso Jiménez Díaz, MD, Brent McLaurin, MD, David A. Brogno, MD, Luc Janssens, MD, Mathias C. Vrolix, MD, Iván Gómez-Blázquez, MD, Zakir H. Sahul, MD, Ameer Kabour, MD, Luisa Salido, MD, Michael Cleman, MD, Shigeru Saito, MD, Martin B. Leon, MD, Andreas Baumbach, MD
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2022-01-01
Col·lecció:	Journal of the Society for Cardiovascular Angiography & Interventions
Matèries:	Drug-eluting stent Percutaneous coronary intervention Coronary revascularization Coronary artery disease Acute coronary syndrome
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2772930321000041
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!